Lexicon Pharmaceuticals reported 10.69M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 44M
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Akebia Therapeutics AKBA:US $ 32.81M 11.52M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
AstraZeneca AZN:LN 3.27B 209M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Clovis Oncology CLVS:US $ 32.59M 3.38M
Coherus Biosciences CHRS:US $ 51.28M 2.52M
Eli Lilly And LLY:US $ 1.63B 67.2M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Illumina ILMN:US $ 308M 118M
Insmed INSM:US $ 59.97M 3.23M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Ironwood Pharmaceuticals IRWD:US $ 30.12M 1.26M
Johnson & Johnson JNJ:US $ 6.23B 288M
Lexicon Pharmaceuticals LXRX:US 10.69M 2.19M
Macrogenics MGNX:US $ 13.67M 2.58M
Mannkind MNKD:US $ 26.04M 5.35M
Merk MRK:US $ 2.42B 118M
Moderna Inc MRNA:US 211M 57M
Novartis NOVN:VX 3.59B 91M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regulus Therapeutics RGLS:US $ 2.89M 339K
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Thermo Fisher Scientific TMO:US $ 1.74B 537M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
United Therapeutics UTHR:US $ 141.5M 62.5M
Vanda Pharmaceuticals VNDA:US $ 33M 7.85M